HROWL logo
HROWL NASDAQ US

Harrow, Inc. - 8.625% senior notes due 2026

Healthcare · Pharmaceuticals Website · IPO Feb 2013
$25.61
+0.05 (+0.2%)
5
Quality Score
fail
Mkt Cap
$1.8B
ROE
-8.9%
Margin
-2.0%
D/E
516.58
Beta
0.07
52W
$21–$51

Wall Street Consensus

14 analysts · Apr 2026
5
Strong Buy
8
Buy
1
Hold
0
Sell
0
Strong Sell
92.9%
Buy Rating

Price Chart

Similar Stocks

MBX
MBX Biosciences Inc
$1.4B
TRVI
Trevi Therapeutics Inc
$1.6B
MAZE
Maze Therapeutics Inc
$2.0B
ATAI
AtaiBeckley Inc
$1.5B
HROW
Harrow Inc
$1.8B
SEPN
Septerna Inc
$1.2B
EYPT
EyePoint Inc
$1.5B
COLL
Collegium Pharmaceutical Inc
P/E 25.0
$1.5B
XERS
Xeris Biopharma Holdings Inc
$1.3B

Earnings

Beat rate: 25.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $0.38 $0.17 $-0.21
Sep 2025 $0.27 $0.22 $-0.05
Jun 2025 $0.01 $0.13 +$0.12
Mar 2025 $-0.05 $-0.50 $-0.45

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -17.5% -17.5% -17.5% -17.5% -9.0% -8.9%
P/E (TTM) — — — — — —
Net Margin 7.8% -4.5% -4.5% -4.5% -2.0% -2.0%
Gross Margin 74.5% 74.6% 74.6% 74.6% 74.6% 74.6%
D/E Ratio 447.30 447.30 447.30 447.30 516.58 516.58
Current Ratio 0.62 0.62 0.62 0.62 2.72 2.72

Key Ratios

ROA (TTM)
-1.4%
P/S (TTM)
7.26
P/B
17.2
EPS (TTM)
$-0.15
CF/Share
$-0.15
Rev Growth 3Y
+40.2%
52W High
$51.30
52W Low
$20.85
$20.85 52-Week Range $51.30

How does HROWL compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

HROWL AARD ACB ACRS ADIL

HROWL valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
7.3
▲ 47% above peers (5.0)
vs Peers
vs Industry
Pricier
P/B ratio
17.2
▲ 709% above peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

HROWL profitability vs Pharmaceuticals peers

ROE
-8.9%
▲ 84% above peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
-2.0%
▲ 96% above peers (-47.4%)
vs Peers
vs Industry
Below avg
Gross margin
74.6%
▲ 9% above peers (68.3%)
vs Peers
vs Industry
Weak
ROA
-1.4%
▲ 96% above peers (-37.4%)
vs Peers
vs Industry
Top tier

HROWL financial health vs Pharmaceuticals peers

D/E ratio
516.6
▲ 33444% above peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
2.7
▼ 19% below peers (3.4)
vs Peers
vs Industry
Below avg
Beta
0.1
▼ 92% below peers (0.9)
vs Peers
vs Industry
More volatile

HROWL fundamentals radar

HROWL Peer median Industry

HROWL profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

HROWL vs peers: key metrics

Latest News

No related news yet